Related Experiment Video
Updated: Sep 25, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
ACE inhibitors are better than diuretics for treatment of hypertension in the elderly
Jenny M Frazier1, Kevin Y Kane
1Department of Family Practice, University of Missouri-Columbia, Columbia, MO, USA. frazierj@health.missouri.edu
Insights
Angiotensin-converting enzyme (ACE) inhibitors show better cardiovascular outcomes than diuretics in elderly hypertensive patients, particularly men. Both drug classes effectively lower blood pressure and prevent complications.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Elderly hypertensive patients receiving angiotensin-converting enzyme (ACE) inhibitors experienced fewer cardiovascular events and lower all-cause mortality compared to those on diuretics, despite similar blood pressure reduction.
- The observed benefits of ACE inhibitors were more pronounced in male patients.
Discussion:
- Results may differ from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) trial due to variations in patient demographics (age, African ancestry), medication brands, and primary outcome definitions.
- Both ACE inhibitors and diuretics represent cost-effective strategies for managing hypertension and preventing associated complications.
Key Insights:
- ACE inhibitors offer superior cardiovascular protection over diuretics in elderly hypertensive men.
- Understanding trial-specific factors is crucial when comparing antihypertensive medication efficacy.
Outlook:
- Further research may explore the specific mechanisms behind ACE inhibitors' enhanced efficacy in elderly men.
- Comparative effectiveness studies in diverse populations are essential for personalized hypertension management.
Abstract:
Despite similar reductions in blood pressure, angiotensin-converting enzyme (ACE) inhibitors demonstrate lower combined rates of cardiovascular events or all-cause mortality in elderly hypertensive patients compared with diuretics. This benefit is most evident in men. These results may differ from those of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) trial because that study included younger patients, had a greater representation of patients with African ancestry, used different brands of medication, and had a slightly different primary outcome. Despite these differences, both treatments offer an inexpensive means for reducing blood pressure and preventing hypertension-related complications.
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Thiazide-Class Diuretics